Key result
Dual-chamber implantable cardioverter defibrillators showed no significant benefit in reducing the occurrence of inappropriate shocks compared to single-chamber devices.
Why the study?
Do dual-chamber implantable cardioverter defibrillators reduce inappropriate shocks in patients with ICDs compared to single-chamber devices?
Meta-Analysis (n=886)
Randomized
Do dual-chamber implantable cardioverter defibrillators reduce inappropriate shocks in patients with ICDs compared to single-chamber devices?
There is no clear evidence that dual-chamber ICDs are superior to single-chamber ICDs in reducing the occurrence of inappropriate shocks.
Answers are grounded in this paper and cite their sources.
Does not support dual-chamber ICD selection to reduce inappropriate shocks; reinforces single-chamber adequacy absent other indications.
BACKGROUND: Despite the technological evolution of the implantable defibrillator, one of the questions that remains is the possible benefit of the dual chamber versus single chamber implantable cardioverter defibrillator (ICD) in reducing inappropriate shocks. OBJECTIVE: To evaluate which type of device provides fewer inappropriate shocks (dual chamber versus single chamber) in patients with implantable cardioverter defibrillators (ICDs). METHODS: Meta-analysis of randomized studies published in the literature comparing dual-chamber implantable cardioverter defibrillators to single chamber devices which have been known to cause, as an evaluated endpoint, inappropriate shocks. RESULTS: The dual-chamber implantable cardioverter showed no benefit in reducing the number of inappropriate shocks. In fact, the opposite was shown. In the analysis of fixed effects, the association tended to favor single-chamber implantable cardioverter defibrillators (OR = 1.53, CI 95%: 0.91-2.57), despite the absence of statistical significance (p = 0.11). We highlight the heterogeneity observed in the results (I² = 53%), which motivated a replication of the analysis using a model of random effects. However, significant differences remained in the occurrence of inappropriate shocks in both groups (OR = 1.1, 95% CI: 0.37-3.31; p = 0.86). To complement the analysis, we proceeded to perform sensitivity analysis, which showed that the exclusion of a study resulted in the lowest heterogeneity observed (I²=24%) and the association with inappropriate shocks significantly favored the single chamber cardiodefibrillator (OR = 1.91; 95% CI: 1.09-3.37; p = 0.27). CONCLUSIONS: It was determined that there was no clear evidence of superiority of any of the devices evaluated.
No takes yet. Share an insight, caveat, or question.
Gonçalves et al. (2013) conducted a meta-analysis in Patients with implantable cardioverter defibrillators (ICDs) (n=886). Dual-chamber implantable cardioverter defibrillator (ICD DR) vs. Single-chamber implantable cardioverter defibrillator (ICD VR) was evaluated on Inappropriate shocks (OR 1.1, 95% CI 0.37-3.31, p=0.86). Dual-chamber implantable cardioverter defibrillators showed no significant benefit in reducing the occurrence of inappropriate shocks compared to single-chamber devices.
Synapse has enriched 10 related papers. Consider them for comparative context: